Page last updated: 2024-08-24

cidofovir anhydrous and Ebola Hemorrhagic Fever

cidofovir anhydrous has been researched along with Ebola Hemorrhagic Fever in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albariño, C; Dyall, J; Flint, M; Foster, S; Hensley, LE; Lanier, ER; McMullan, LK; Nichol, ST; Olinger, GG; Sethna, P; Spiropoulou, CF	1

Other Studies

1 other study(ies) available for cidofovir anhydrous and Ebola Hemorrhagic Fever

Article	Year
The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus. Antiviral research, 2016, Volume: 125 Topics: Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Ebolavirus; HeLa Cells; Hemorrhagic Fever, Ebola; Human Umbilical Vein Endothelial Cells; Humans; Lipids; Male; Organophosphonates; Structure-Activity Relationship; Vero Cells; Virus Replication	2016

Article

Year

The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus.

Antiviral research, 2016, Volume: 125

Topics: Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Ebolavirus; HeLa Cells; Hemorrhagic Fever, Ebola; Human Umbilical Vein Endothelial Cells; Humans; Lipids; Male; Organophosphonates; Structure-Activity Relationship; Vero Cells; Virus Replication

2016